Prostate cancer (PCa) is the second most diagnosed cancer in men worldwide. For its
screening, serum prostate specific antigen (PSA) test has been largely performed over the …

Simple Summary The lack of highly specific and sensitive biomarkers for the early detection
of prostate cancer (PCa) is a major barrier to its management. Volatilomics emerged as a …

Diagnosis of prostate cancer via PCA3 biomarker detection is promising to be much more
efficient than with the prostatic specific antigens currently used. In this study, we present the …

The development of simple detection methods aimed at widespread screening and testing is
crucial for many infections and diseases, including prostate cancer where early diagnosis …

Anticancer therapeutics with profiles of high potency, low toxicity, and low resistance is of
considerable interest. A new series of functionalized spirooxindole linked with 3-acylindole …

Purpose Ferroptosis is a type of cell death that is iron dependent, a characteristic that
distinguishes it from necrosis, apoptosis, and autophagy. However, the ferroptotic …

Background Exosomes are nano-sized membrane vesicles, secreted by different types of
cells into the body's biological fluids. They are found in abundance in semen as compared to …

Abstract Background Prostate cancer (PCa) screening using serum prostate-specific antigen
(PSA) testing has caused unnecessary biopsies and overdiagnosis owing to its low …

Prostate cancer is one of the most frequently diagnosed male malignancies and can be
detected by prostate-specific antigen (PSA) as a biomarker. To detect PSA, several studies …

BACKGROUND Prostate cancer is the most common cancer among men in the UK. Prostate-
specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as …